Involvement of glutathione peroxidase activity in the stimulation of 5‐lipoxygenase activity by glutathione‐depleting agents in human polymorphonuclear leukocytes
Open Access
- 1 April 1989
- journal article
- research article
- Published by Wiley in European Journal of Biochemistry
- Vol. 180 (3) , 527-533
- https://doi.org/10.1111/j.1432-1033.1989.tb14678.x
Abstract
We recently demonstrated activation of 5-lipoxygenase activity in human polymorphonuclear leukocytes (PMN) on preincubation of the cells with glutathione-depleting agents, namely 1-chloro-2,4-dinitrobenzene (Dnp-Cl) and azodicarboxylic acid bis[dimethylamide] (diamide). In this paper we show that Dnp-Cl, but not diamide, impairs the reduction of added organic peroxides in whole PMN. Also, since co-incubation of fatty acid hydroperoxides with arachidonate caused activation of 5-lipoxygenase, we propose that Dnp-Cl increases the peroxide level in PMN which is required for the onset of lipoxygenase activity. This could be substantiated in PMN homogenates by a glutathione-dependent depression of arachidonate 5-lipoxygenation. At higher arachidonate concentrations and in the presence of Ca2+ the glutathione effect was not observed but additional glutathione peroxidase also blocked this maximally stimulated 5-lipoxygenase. Together with other experiments, it became obvious that the formation of leukotrienes, but also of 15-lipoxygenase products, requires a sharply defined threshold level of fatty acid hydroperoxides which are generated by the lipoxygenases and counteracted by glutathione-dependent peroxidase(s). Dnp-Cl influences this equilibrium by removing glutathione and thereby inhibiting glutathione-dependent peroxidase activity. Form our data we conclude that it is the physiological function of the peroxidase activity in PMN to determine an efficiently regulated threshold level of hydroperoxide products, below which no activation of 5-lipoxygenase or 15-lipoxygenase can occur.This publication has 35 references indexed in Scilit:
- The ω‐hydroxylation of arachidonic acid by human polymorphonuclear leukocytesEuropean Journal of Biochemistry, 1988
- Arachidonate 15-lipoxygenase from human eosinophil-enriched leukocytes: Partial purification and propertiesBiochemical and Biophysical Research Communications, 1988
- Neutrophils in Human DiseasesNew England Journal of Medicine, 1987
- The importance of hydroperoxide activation for the detection and assay of mammalian 5‐lipoxygenaseFEBS Letters, 1986
- Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and InflammationScience, 1983
- Leukotriene‐induced neutrophil aggregation in vitroFEBS Letters, 1982
- Stimulation of human leukocyte degranulation by leukotriene B4 and its ω‐oxidized metabolitesFEBS Letters, 1981
- Identification and biological activity of novel ω‐oxidized metabolites of leukotriene B4 from human leukocytesFEBS Letters, 1981
- Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesNature, 1980
- Metabolism of arachidonic acid in ionophore-stimulated neutrophils. Esterification of a hydroxylated metabolite into phospholipids.Journal of Clinical Investigation, 1979